Post-IPO Equity Therapeutics Companies

Chinook Therapeutics is a biotechnology company that specializes in the fields of therapeutics and life science.

Cantargia develops a therapy for the treatment of cancer by targeting a unique cell-surface receptor on malignant stem cells.

Relay therapeutics is a developer of an allosteric drug-discovery platform intended to apply computational techniques to protein motion.

Quince Therapeutics is developing treatments for Alzheimer's and other degenerative disorders.

Ikena Oncology develops differentiated therapies to target cancer growth and resistance, focusing on Hippo and RAS signaling pathways.

XORTX Therapeutics is a BioPharmaceutical company focused on developing innovative therapies to treat progressive kidney disease

Lantern Pharma is a clinical stage biopharma company developing precision oncology therapies leveraging A.I., machine learning, and genomics

Atara Biotherapeutics (Nasdaq: ATRA) is an off-the-shelf, allogeneic T-cell immunotherapy company.

Emria is a data-backed drug development and care delivery company.

Revitalist uses cutting-edge, evidence-based treatments for mental health, chronic pain, and general wellness.

Tevogen Bio develops immunotherapy solutions for treating cancer, neurological conditions, and viral infections.

Pulse Biosciences is a medical device company that engages in the research and development, and commercialization of CellFX system.

Stayble Therapeutics is developing a minimally invasive injection-based treatment against chronic low back pain.

Thiogenesis Therapeutics is a clinical-stage biotech company that develops thiol-active therapeutics to treat medical diseases.

Acrivon Therapeutics is a precision oncology therapeutics company specializing in drug development through early clinical treatment success.

Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.

VeraDermics is a dermatology company that creates novel drug delivery mechanisms for a pain-free cure for skin conditions.

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Lucid Diagnostics develops a non-invasive, office based diagnostic test for biomarkers to esophageal cancer.

Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases.

OS Therapies is a therapeutics company focused on the identification, development, and commercialization of treatments for osteosarcoma.

Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.

Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.

CERo Therapeutics, Inc. is a new cellular immunotherapy company.

Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.